✉news HealthMedicine first seen 9 h ago, last 8 h ago, peak #32
Laverock Therapeutics unveils in vivo oncology and genetic medicine programs
Original: Laverock Therapeutics announces in vivo programs in oncology and genetic medicine
Laverock Therapeutics has announced new in vivo programs spanning oncology and genetic medicine, marking an expansion of the company's pipeline into therapies delivered directly within the body. The biotech says the move broadens its development focus in cell and gene therapy. Details on specific targets and timelines have not yet been widely reported.
Why now: The announcement signals pipeline expansion at a gene therapy company, drawing attention from biotech and medical communities.
Rank over time, top of the chart is #1. 2 snapshots from 9 h ago to 8 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/515361